Eli Lilly's Chief Scientific Officer Dan Skovronsky says the company wants to take big swings in Alzheimer's, ALS, chronic pain and other difficult diseases after its success in obesity.
Original Image Link
Source:www.msn.com
Original Image Link
Source:www.msn.com
Posted: 2025-02-20 05:54:00